Methods in Drug Repurposing: Emphasis on COVID-19

Author:

Kumar Maurya Akhilesh1,Mishra Nidhi2

Affiliation:

1. Indian Institute of Information Technology Allahabad,Department of Applied Sciences,,Prayagraj,India,211012,

2. Indian Institute of Information Technology Allahabad,Department of Applied Sciences,Prayagraj,India,211012,

Abstract

Coronavirus disease 19 (COVID-19) is a pandemic situation caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), and dedicated medical research finding to cure the disease are rapidly evolving globally. SARS-Co- -2 is a highly mutating virus having various strains, till the reporting of this study, COVID-19 has 5 variants, i.e., Alfa, beta, gamma, delta, and omicron. A potential way for drug development is drug repurposing has got a lot of attention. Drug repurposing is the easiest and safest way to find out the drugs to cure COVID-19. Various new drugs have been discovered and are under clinical trial for the treatment of disease. Combinatorial treatments of COVID-19 patients give a very positive response in the treatment of SARS-CoV-2. The various vaccine already has been developed to produce antibodies against COVID-19. However, a large number of research studies have been done on COVID-19. This study is dedicated to research on COVID-19 therapy by the repurposing of existing drugs and methods used for the drug repurposing.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference53 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3